Vera Therapeutics, Inc.
Ticker: 1831828
values in millions
| Period | Q3 FY26 |
|---|---|
| INCOME | |
| Revenue | 10.28 |
| Total Income | 10.28 |
| EXPENSES | |
| Expenditure | 105.98 |
| PROFIT | |
| Net Profit | -93.71 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -100.00% |
| EPS | -1.30 |
Corporate Events
Board MeetingVERA
20269Jul
Board Meeting
Chief Regulatory Officer Transition — William Turner to reti…
SEC Filing ↗ Board MeetingVERA
202621May
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II Direct…
SEC Filing ↗